Concepedia
4
Publications
118
Citations
H-Index
2016
Active since
Affiliations
AstraZeneca (Brazil)(Current)
Mario Scarpa is an author at AstraZeneca (Brazil).
Publications per year
2016–2021
Concurrent Inhibition of Pim and FLT3 Kinases Enhances Apoptosis of FLT3-ITD Acute Myeloid Leukemia Cells through Increased Mcl-1 Proteasomal Degradation
Shivani Kapoor, Karthika Natarajan, Patrick R. Baldwin et al. · Clinical Cancer Research · 2017 · 49 citations · Full text
Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells
Dario Palmieri, Mario Scarpa, Anna Tessari et al. · Oncotarget · 2016 · 33 citations · Full text
PP2A-activating Drugs Enhance FLT3 Inhibitor Efficacy through AKT Inhibition–Dependent GSK-3β–Mediated c-Myc and Pim-1 Proteasomal Degradation
Mario Scarpa, Prerna Singh, Christopher M. Bailey et al. · Molecular Cancer Therapeutics · 2021 · 22 citations · Full text
Oncofetal Protein CRIPTO Is Involved in Wound Healing and Fibrogenesis in the Regenerating Liver and Is Associated with the Initial Stages of Cardiac Fibrosis
Sofia Karkampouna, Danny van der Helm, Mario Scarpa et al. · Cells · 2021 · 14 citations · Full text
Rows per page
1–4 of 4